Reuters logo
BRIEF-Chongqing Lummy Pharmaceutical gets nod for clinic trial
November 7, 2016 / 7:43 AM / a year ago

BRIEF-Chongqing Lummy Pharmaceutical gets nod for clinic trial

Nov 7 (Reuters) - Chongqing Lummy Pharmaceutical Co Ltd :

* Says it gets China Food and Drug Administration’s approval for its imatinib mesylate tablets’ clinic trial

Source text in Chinese: goo.gl/FxrTMj

Further company Coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below